These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 35077773)
1. 2021: The year in review. Ballas ZK J Allergy Clin Immunol; 2022 Mar; 149(3):887-889. PubMed ID: 35077773 [No Abstract] [Full Text] [Related]
2. Immunology Lessons from the SARS-CoV-2 Pandemic. Yokoyama WM; Hogquist KA; O'Shea JJ Annu Rev Immunol; 2021 Apr; 39():v-vii. PubMed ID: 33939926 [No Abstract] [Full Text] [Related]
3. Why COVID vaccines are so difficult to compare. Ledford H Nature; 2021 Mar; 591(7848):16-17. PubMed ID: 33623151 [No Abstract] [Full Text] [Related]
4. SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? Heldman MR; Limaye AP J Am Soc Nephrol; 2021 May; 32(5):1021-1024. PubMed ID: 33762353 [No Abstract] [Full Text] [Related]
5. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates. Behr MA; Divangahi M; Schurr E J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239 [TBL] [Abstract][Full Text] [Related]
6. Immunity to glycan α-Gal and possibilities for the control of COVID-19. la Fuente J; Gortázar C; Cabezas-Cruz A Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805 [No Abstract] [Full Text] [Related]
7. Impact of COVID-19 pandemic on EJI and the extended immunological community. Di Santo J Eur J Immunol; 2021 Jan; 51(1):8-9. PubMed ID: 33616920 [No Abstract] [Full Text] [Related]
8. COVID-19: release approved vaccines for trials of new ones. Saville M Nature; 2021 Sep; 597(7875):178. PubMed ID: 34493842 [No Abstract] [Full Text] [Related]
10. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges. Abdullahi IN; Emeribe AU; Adekola HA; Abubakar SD; Dangana A; Shuwa HA; Nwoba ST; Mustapha JO; Haruna MT; Olowookere KA; Animasaun OS; Ugwu CE; Onoja SO; Gadama AS; Mohammed M; Daneji IM; Amadu DO; Ghamba PE; Onukegbe NB; Shehu MS; Isomah C; Babayo A; Ahmad AE Hum Vaccin Immunother; 2021 Mar; 17(3):620-637. PubMed ID: 32936732 [TBL] [Abstract][Full Text] [Related]
11. How 'killer' T cells could boost COVID immunity in face of new variants. Ledford H Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217 [No Abstract] [Full Text] [Related]